Cargando…

Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma

Lung adenocarcinoma is often diagnosed at an advanced stage with poor prognosis. Patients with different clinical outcomes may have similar clinico-pathological characteristics. The results of previous studies for biomarkers for lung adenocarcinoma have generally been inconsistent and limited in cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ya-Hsuan, Chen, Chung-Ming, Chen, Hsuan-Yu, Yang, Pan-Chyr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455286/ https://www.ncbi.nlm.nih.gov/pubmed/26042604 http://dx.doi.org/10.1038/srep10979

Ejemplares similares

Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma
por: Raghav, Lovely, et al.
Publicado: (2020)

Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
por: Su, Kang-Yi, et al.
Publicado: (2018)

EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
por: Chen, Hsuan-Yu, et al.
Publicado: (2016)

The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma
por: Hung, Pei-Fang, et al.
Publicado: (2013)

PM2.5 promotes lung cancer progression through activation of the AhR‐TMPRSS2‐IL18 pathway
por: Wang, Tong‐Hong, et al.
Publicado: (2023)

Molecular gene signature and prognosis of non-small cell lung cancer
por: Huang, Poyin, et al.
Publicado: (2016)

Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma
por: Wu, Chunlei, et al.
Publicado: (2021)

Identification of age‐ and immune‐related gene signatures for clinical outcome prediction in lung adenocarcinoma
por: Zhou, Andrew, et al.
Publicado: (2023)

CRSD: a comprehensive web server for composite regulatory signature discovery
por: Liu, Chun-Chi, et al.
Publicado: (2006)

Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan
por: Hsu, Kuo-Hsuan, et al.
Publicado: (2015)

Fanconi anemia genes in lung adenocarcinoma- a pathway-wide study on cancer susceptibility
por: Yang, Shi-Yi, et al.
Publicado: (2016)

Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses
por: Chen, Donglai, et al.
Publicado: (2021)

Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma
por: Wang, Sheng, et al.
Publicado: (2021)

An individualized gene expression signature for prediction of lung adenocarcinoma metastases
por: Qi, Lishuang, et al.
Publicado: (2017)

Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Zhang, Yingqing, et al.
Publicado: (2020)

A Lipid Metabolism-Based Seven-Gene Signature Correlates with the Clinical Outcome of Lung Adenocarcinoma
por: Li, Tianqi, et al.
Publicado: (2022)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma
por: Cao, Xueting, et al.
Publicado: (2023)

Targeting androgen receptor as a new potential therapeutic approach to battle tobacco carcinogens-induced non-small cell lung cancer
por: Yeh, Shauh-Der, et al.
Publicado: (2012)

Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
por: Lin, Ching-Wen, et al.
Publicado: (2016)

Tumor mutation burden and recurrent tumors in hereditary lung cancer
por: Hsu, Yi‐Chiung, et al.
Publicado: (2019)

Corrigendum: Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
por: Lin, Ching-Wen, et al.
Publicado: (2017)

Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes
por: Liu, Chia-Hsin, et al.
Publicado: (2023)

Tumor Purity Coexpressed Genes Related to Immune Microenvironment and Clinical Outcomes of Lung Adenocarcinoma
por: Bai, Ming, et al.
Publicado: (2021)

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma
por: Liang, Jin-xiao, et al.
Publicado: (2022)

Systematic profiling of invasion‐related gene signature predicts prognostic features of lung adenocarcinoma
por: Yu, Ping, et al.
Publicado: (2021)

DNA Repair-Based Gene Expression Signature and Distinct Molecular Subtypes for Prediction of Clinical Outcomes in Lung Adenocarcinoma
por: Hu, Bin, et al.
Publicado: (2020)

Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes
por: Chang, Chia-Ching, et al.
Publicado: (2022)

Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma
por: Ye, Wei, et al.
Publicado: (2022)

Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma
por: Chang, Jan-Gowth, et al.
Publicado: (2016)

Computational detection of a genome instability‐derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma
por: Guo, Chen‐Rui, et al.
Publicado: (2021)

An 11-gene signature for the prediction of systemic recurrences in colon adenocarcinoma
por: Cai, Jia-Wei, et al.
Publicado: (2021)

Circulating miRNA signature for early diagnosis of lung cancer
por: Lin, Pei-Ying, et al.
Publicado: (2011)

An aging‐related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma
por: Zhang, Wenjing, et al.
Publicado: (2022)

Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein
por: Meng, Liangliang, et al.
Publicado: (2020)

Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis
por: Hsu, Ya-Ling, et al.
Publicado: (2017)

Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2022)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

Identification of reproducible gene expression signatures in lung adenocarcinoma
por: Lu, Tzu-Pin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uat7cq295u87bhavpvadku1h2j